Drug Safety Open Access
Pharmacovigilance is beneficial in assuring the security of medicines and protecting the consumers from their harmful effects. A number of single
drugs also as fixed dose combinations are banned from manufacturing,
marketing and distribution in India. Drug withdrawals from market were made mainly thanks to questions of safety involving
cardiovascular events (57.14%) and liver damage (14.28%). Majority of medicine are banned since 3-5 years in other countries but are still available purchasable in India. The present drug safety monitoring systems within the developed countries like the USA and UK and provides measurements for developing a system which will ensure the safety and efficacy of
drugs in India. Highest quality level is absent for a medication security TV , varieties in culture and clinical practice across nations makes it hard for India to totally embrace another nation's practices. Data got from patients and social insurance suppliers through
pharmacovigilance understandings (PVAs), additionally as different sources like the clinical writing, assumes a basic job in giving the
information important to
pharmacovigilance to occur. Truth be told, in order to plug or to check a pharmaceutical item in many nations, unfavorable occasion
information got by the permit holder (generally a pharmaceutical organization) must be submitted to the neighborhood sedate administrative power.
High Impact List of Articles
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Alzheimers disease vaccines: promises and pitfalls
Takeshi Tabira
Therapeutic Prospective: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
-
Is there a future for CETP-inhibitor therapy?
Jennifer G Robinson
Editorial: Clinical Investigation
Relevant Topics in Clinical